Avecho Biotechnology Limited | ASX: AVE | ACN: 056 482 403 | ABN: 32 056 482 403 Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168 avecho.com.au ASX Announcement 24 August 2026 Avecho...
Avecho strengthens BD capability with senior appointment
Filed with ASX · · 3 pages · English
Release
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Small Holding Share Sale Facility Completion
- Japanese patent granted for CBD capsule
- June 2026 Quarterly Activities Report & Appendix 4C
- Positive interim analysis advances Avecho Phase III insomnia program
- Positive interim results from Phase III insomnia program
Later from Avecho Biotechnology
- Appendix 4D and Half-year Financial Report
- Avecho enters final stage of Phase III insomnia trial
- Avecho to present at the ASX SMIDcaps Conference
- Avecho to present at the Canaccord Drug and Device Confe
- Response to ASX Price Query
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology